Patent Office Puts Allergan’s Mohawk Deal Out Of Its Misery
Source: GW Law – The George Washington University. In a much-anticipated ruling the Patent Trial And Appeal Board (“PTAB”) of the U.S. Patent And Trademark Office ruled the St. Regis Mohawk Tribe could not claim sovereign immunity to void an inter partes review (“IPR”) for dry-eye drug Restasis:.